[ij] [ij] [ij] 
Email id

Research Journal of Pharmacy and Technology
Year : 2012, Volume : 5, Issue : 5
First page : ( 635) Last page : ( 640)
Print ISSN : 0974-3618. Online ISSN : 0974-360X.

Formulation and Evaluation of Oral Suspension of Oseltamivir Phosphate Using Different Vehicle

Sisodiya Dharmendra Singh*, Soni Anuraj, Patel Ronak, Majji Uma Sankar Rao, Khirwadkar Praveen

B.N. College of Pharmacy, Udaipur (Raj.)

*Corresponding Author E-mail: ds.sisodiya27@gmail.com

Online published on 12 February, 2013.


Oseltamivir phosphate is used in the treatment and prophylaxis of both influenza A and influenza B. Oseltamivir is readily absorbed from the gastrointestinal tract after oral administration of oseltamivir phosphate and is extensively converted predominantly by hepatic esterases to oseltamivir phosphate. At least 75% of an oral dose reaches the systemic circulation as oseltamivir phosphate. Exposure to oseltamivir is less than 5% of the total exposure after oral dosing. So in oral dosage form it give high bioavability. A wide choice of vehicles ranging for oral suspension development for a good dosage form must important of choosing of a good vehicle.



Oseltamivir phosphate, vehicle, oral suspension, dosage form.


║ Site map ║ Privacy Policy ║ Copyright ║ Terms & Conditions ║ Page Rank Tool
721,779,864 visitor(s) since 30th May, 2005.
All rights reserved. Site designed and maintained by DIVA ENTERPRISES PVT. LTD..
Note: Please use Internet Explorer (6.0 or above). Some functionalities may not work in other browsers.